National Research (NASDAQ:NRC) Earns Mkt Outperform Rating from Analysts at Citizens Jmp

Equities researchers at Citizens Jmp initiated coverage on shares of National Research (NASDAQ:NRC) in a research note issued to investors on Monday, Marketbeat.com reports. The brokerage set a “mkt outperform” rating and a $23.00 price target on the stock. Citizens Jmp’s target price would suggest a potential upside of 22.07% from the stock’s current price.

Separately, Weiss Ratings upgraded National Research from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Friday, May 29th. One research analyst has rated the stock with a Hold rating, According to data from MarketBeat, the stock presently has an average rating of “Hold” and an average target price of $23.00.

National Research Price Performance

NASDAQ:NRC traded up $0.30 on Monday, reaching $18.84. The stock had a trading volume of 4,566 shares, compared to its average volume of 112,653. The company has a quick ratio of 0.52, a current ratio of 0.52 and a debt-to-equity ratio of 5.48. The company has a market capitalization of $428.63 million, a P/E ratio of 48.03 and a beta of 0.36. National Research has a 1-year low of $11.01 and a 1-year high of $22.79. The stock has a fifty day moving average price of $18.44 and a 200-day moving average price of $17.66.

National Research (NASDAQ:NRC) last posted its quarterly earnings data on Tuesday, April 28th. The company reported $0.21 earnings per share for the quarter. National Research had a net margin of 6.52% and a return on equity of 122.73%. The company had revenue of $34.80 million during the quarter.

Institutional Investors Weigh In On National Research

Hedge funds have recently added to or reduced their stakes in the stock. M&T Bank Corp lifted its holdings in National Research by 6.4% during the second quarter. M&T Bank Corp now owns 13,608 shares of the company’s stock worth $229,000 after acquiring an additional 823 shares in the last quarter. Sei Investments Co. grew its stake in National Research by 1.2% in the third quarter. Sei Investments Co. now owns 76,270 shares of the company’s stock valued at $975,000 after acquiring an additional 900 shares during the period. Russell Investments Group Ltd. increased its holdings in shares of National Research by 85.6% in the third quarter. Russell Investments Group Ltd. now owns 1,997 shares of the company’s stock worth $26,000 after acquiring an additional 921 shares in the last quarter. Invesco Ltd. increased its holdings in shares of National Research by 6.3% in the second quarter. Invesco Ltd. now owns 17,368 shares of the company’s stock worth $292,000 after acquiring an additional 1,022 shares in the last quarter. Finally, Alliancebernstein L.P. increased its holdings in shares of National Research by 6.3% in the third quarter. Alliancebernstein L.P. now owns 18,499 shares of the company’s stock worth $236,000 after acquiring an additional 1,100 shares in the last quarter. Institutional investors own 47.26% of the company’s stock.

About National Research

National Research Corp (NASDAQ: NRC), also known as NRC Health, is a healthcare analytics and performance improvement company specializing in patient and employee experience measurement. The company’s cloud-based platform enables healthcare providers to collect real-time feedback through patient satisfaction surveys, post-discharge outreach, and employee engagement tools. NRC Health integrates clinical, operational and financial data to deliver actionable insights that support quality improvement initiatives and value-based care programs.

Since its founding in the early 1990s and headquartered in Lincoln, Nebraska, National Research has expanded beyond its regional roots to serve more than 1,600 hospitals and 12,000 care sites across the United States and Canada.